|47.01|| +0.31 / +0.66%|
Zoetis, Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The company manages its operations in four geographic regional segments: the United States, Europe/Africa/Middle East, Canada/Latin America and Asia/Pacific. Within each of these regions, it offers a diversified product portfolio, including vaccines, parasiticides, anti-infectives, medicated feed additives and other pharmaceuticals, for both livestock and companion animal customers. The company's origin dates back to Jan 1, 1952, when it was established as a division of Pfizer, Inc. Zoetis was founded in July 2012 and is headquartered in New York, NY.
|Juan Ramón Alaix||President, Chief Executive Officer & Director|
|Paul S. Herendeen||Chief Financial Officer & Executive Vice President|
|Catherine Ann Knupp||Executive VP, President-Research & Development|
|Alejandro Bernal||Executive Vice President & President-EMEA Region|
|Clinton A. Lewis||Executive VP & President-International Operations|